Its GMP plasmid production site, located in Guangzhou, China, is dedicated to providing plasmid production services.
PackGene's proprietary π-Alpha 293 AAV high-yield platform, is a triple-plasmid transfection system that uses uniquely designed RC plasmid to increase AAV production by three to eight times in various AAV serotypes.
PackGene provides economical, reliable, and scalable plasmid DNA and AAV viral vector production for early-stage drug discovery, preclinical development, and clinical trials for cell and gene therapy.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze